摘要
探讨经尿道丝裂霉素粘膜下注射对降低MTC治疗膀胱癌复发的效果。方法:将经尿道MTC加丝裂霉素粘膜下注射及膀胱灌注,与经尿道MTC后单纯丝裂霉素膀胱灌注的膀胱癌患者进行疗效比较。结果:观察组83例中78例得到随访,11例分别在治疗后6～36个月后复发,复发率为14.1%。对照组47例中,43例得到随访,17例分别在治疗后6～24个月后复发,复发率为39.5%。结论:丝裂霉素粘膜下注射的方法,对提高MTC治疗效果,减少肿瘤复发,延长无瘤间期,有明显效果。并具有:操作简单,安全,恢复快等优点。
To evaluate the preventive effect of transurethral submucosal injection of mitomycin on recurrence of cystic cancer. Methods:The effects of transurethral microwave tissue coagulation (MTC) plus submucosal injection of mitomycin and intracystic perfusion on cystic cancer patients (therapeutic group) were compared with those only of intracystic MTC and mitomycin perfusion (control group). Results:Among 83 cases in therapeutic group, 78 cases were followed up and 11 cases relapsed in 6-36 months after treatment. Their recurrent rate was 14.1 % . Among 47 cases in control group,43 cases were followed up and 17 cases relapsed in 6-24 months after treatment. Their recurrent rate was 39.5% . Conclusion:The submucosal injection of mitomycin has a significant efficacy for improving the curative effect of MTC, reducing cancer recurrence and prolonging the tumor-free interval. This is a simple, easy, safe and effective therapeutic method for cystic cancer.
出处
《天津医药》
CAS
北大核心
2001年第1期32-33,共2页
Tianjin Medical Journal
